Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5711 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Kourtney Davis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Global Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, USA. Hauptthemen laut MEDLINE: Breast Feeding, Lactation. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Stillen
Abstract (Originalsprache)
Purpose
Most pregnant people take at least one medication during gestation or while breastfeeding, however data are lacking on the safety of medication use in these populations. We conducted a landscape review of real‐world data sources specific to medication use in pregnancy and breastfeeding populations that have met, or have potential to meet, health authorities' requirements for post‐authorization safety studies.
Methods
A 2‐phase approach identified data sources from literature, publicly available registers of non‐interventional post‐authorization studies of pregnant women, existing database inventories, and emerging data sources known to the authors.
Results
Required key attributes were assessed according to current regulatory guidance, resulting in selection of 49 suitable data sources. All global regions were represented, with North America (37%) and Europe (33%) most common; 12% of the data sources included pregnancy information from low‐to middle‐income countries. Administrative healthcare claims (25%) and electronic healthcare records (21%) comprised the largest types of data sources. Across data sources, 53% were managed by national or regional governments, 27% by industry, and 20% by academic institutions. Maternal age, diagnoses, prenatal care, and reproductive history were available in most, whereas fewer included demographic data (e.g., race/ethnicity). Breastfeeding data were collected in 37% of the final data sources.
Conclusion
We conducted a systematic approach to data source evaluation of pregnancy and breastfeeding to be used as a resource for investigators to consider when designing pregnancy‐related research studies to satisfy regulatory requirements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, USA.
- Real World & Late Phase, Syneos Health, Morrisville, North Carolina, USA.
- Medical Affairs, Janssen Biologics B.V, Leiden, The Netherlands.
- Data Sciences, Janssen Research and Development, LLC, New Brunswick, New Jersey, USA.
- Global Public Health, Johnson & Johnson, Zug, Switzerland.
ORCID-Profile: Emily Yost
Zitieren
APA
Davis, K., Yost, E., Brauneis, J., Krumme, A., Geldhof, A., Tuck, A., Sylvester, S., & Ephross, S. (2024). Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5711
Vancouver
Davis K, Yost E, Brauneis J, Krumme A, Geldhof A, Tuck A, et al. Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5711
BibTeX
@article{Davis2024,
author = {Davis, Kourtney and Yost, Emily and Brauneis, Jacquelyne and Krumme, Alexis and Geldhof, Anja and Tuck, Astrud and Sylvester, Shirley and Ephross, Sara},
title = {Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5711}
}
EUVIMED